Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa
NCT03894956 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46
Last updated 2022-11-03
Summary
The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.
Conditions
- Hidradenitis Suppurativa (HS)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
ABBVIE INC. · AbbVie
Eligibility
- Min Age
- 0 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-05-02
- Primary Completion
- 2021-11-10
- Completion
- 2021-11-10
Countries
- Japan
Study Locations
More Related Trials
-
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
NCT04242446 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.
NCT03248531 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
NCT06840392 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
NCT03569371 ·Status: COMPLETED ·Phase: PHASE2
-
A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa
NCT01704534 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients
NCT02421172 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)
NCT06959225 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)
NCT06958211 ·Status: RECRUITING ·Phase: PHASE3
-
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS.
NCT07228390 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)
NCT04750213 ·Status: COMPLETED
-
Study of Belimumab Administered Subcutaneously to Healthy Subjects
NCT01583530 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
NCT05635838 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
NCT06895499 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa
NCT00795574 ·Status: COMPLETED ·Phase: PHASE2
-
Anifrolumab for Hidradenitis Suppurativa
NCT06374212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
NCT03628924 ·Status: COMPLETED ·Phase: PHASE2
-
Hidradenitis Suppurativa Phase 2b Study of Izokibep
NCT05355805 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06411379 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
NCT07049575 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of Bermekimab in Patients With Hidradenitis Suppurativa
NCT03512275 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06411899 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects
NCT03497273 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3041658 in Adults With Hidradenitis Suppurativa
NCT04493502 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
NCT06921850 ·Status: RECRUITING ·Phase: PHASE3
-
Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD)
NCT02959944 ·Status: COMPLETED ·Phase: PHASE3